Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Comorbid Tobacco and Cannabis Use in Veterans
NCT05294263Phase 2Withdrawn
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tobacco Use Disorder (TUD) and cannabis use disorder (CUD) comparing Varenicline with Placebo (2 arms). Primary endpoints: Number of cannabis using days and Average number cigarettes smoked per day. Planned start Apr 2023; status: withdrawn.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT05294263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294263.